$KITE a Surprise Coming This Earnings Season? – Tale of the Tape

0
592
Biotech Stocks

Is a Surprise Coming for Kite Pharma (KITE) This Earnings Season? – Tale of the Tape

Investors are always looking for stocks that are poised to beat at earnings season and Kite Pharma, Inc. (KITE) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because KITE is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings—with the most up-to-date information possible—is a pretty good indicator of some favorable trends underneath the surface for KITE in this report.

In fact, the Most Accurate Estimate for the current quarter is currently at loss of 12 cents per share for KITE, compared to a broader Zacks Consensus Estimate of loss of 16 cents per share. This suggests that analysts have very recently bumped up their estimates for KITE, giving the stock a Zacks Earnings ESP of 25% heading into earnings season.

Why is this Important?

A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10 year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).

Given that KITE has a Zacks Rank #3 (Hold) and an ESP in positive territory, investors might want to consider this stock ahead of earnings. Clearly, recent earnings estimate revisions suggest that good things are ahead for Kite Pharma, and that a beat might be in the cards for the upcoming report.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

 

 

 
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

KITE PHARMA INC (KITE): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

LEAVE A REPLY

Please enter your comment!
Please enter your name here